Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Monte Rosa Therapeutics, Inc. Common Stock (GLUE)

Biological Products, (no Disgnostic Substances)

https://www.monterosatx.com

Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade therapeutically relevant proteins. It has developed a protein degradation platform, called QuEEN, that enables to rapidly identify protein targets and molecular glue degrader, or MGD, product candidates.

321 HARRISON AVENUE, SUITE 900
BOSTON, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/24/2021

Market Cap

285,383,520

Shares Outstanding

50,080,000

Weighted SO

50,081,023

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

NKTX --.--%

LYEL --.--%

GBIO --.--%

SANA --.--%

DSGN --.--%

HOWL --.--%

IKNA --.--%

STOK --.--%

FHTX --.--%

Beta

1.3880

Last Div

0.0000

Range

2.44-8.84

Chg

-0.2500

Avg Vol

232424

Mkt Cap

285383520

Exch

NASDAQ

Country

US

Phone

617 949 2643

DCF Diff

3.0434

DCF

1.5966

Div Yield

0.0000

P/S

19.6667

EV Multiple

-1.6532

P/FV

1.4743

Div Yield %

0.0000

P/E

-2.5399

PEG

0.1375

Payout

0.0000

Current Ratio

6.5622

Quick Ratio

6.5622

Cash Ratio

2.5703

DSO

247.5591

DIO

0.0000

Op Cycle

247.5591

DPO

309.3682

CCC

-61.8091

Gross Margin

0.4737

Op Margin

-9.6079

Pretax Margin

-8.9540

Net Margin

-8.9873

Eff Tax Rate

-0.0011

ROA

-0.3790

ROE

-0.7040

ROCE

-0.4620

NI/EBT

1.0037

EBT/EBIT

0.9319

EBIT/Rev

-9.6079

Debt Ratio

0.1289

D/E

0.1974

LT Debt/Cap

0.1540

Total Debt/Cap

0.1649

Int Coverage

-149.1123

CF/Debt

-1.3753

Equity Multi

1.5316

Rec Turnover

1.4744

Pay Turnover

1.1798

Inv Turnover

999999.9999

FA Turnover

0.2373

Asset Turnover

0.0422

OCF/Share

-0.8564

FCF/Share

-0.9512

Cash/Share

3.6809

OCF/Sales

-4.2040

FCF/OCF

1.1107

CF Coverage

-1.3753

ST Coverage

-17.5753

CapEx Coverage

-9.0323

Div&CapEx Cov

-9.0323

P/BV

1.4743

P/B

1.4743

P/S

19.6667

P/E

-2.5399

P/FCF

-4.2118

P/OCF

-5.4298

P/CF

-5.4298

PEG

0.1375

P/S

19.6667

EV Multiple

-1.6532

P/FV

1.4743

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 26, 16:30 Monte Rosa Therapeutics Announces $25 Million Registered Direct Offering, Priced At- the-Market Under Nasdaq Rules

Revenue Product Segmentation